Efficacy and Safety of Antihyperglycemic Agents Added to Metformin Monotherapy in Patients with Type 2 Diabetes

被引:0
|
作者
Mearns, Elizabeth S.
Sobieraj, Diana M.
White, C. Michael
Saulsberry, Whitney J.
Doleh, Yunes
Zaccaro, Eric
Coleman, Craig I.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2602-PO
引用
收藏
页码:A658 / A658
页数:1
相关论文
共 50 条
  • [21] Efficacy and safety of supaglutide monotherapy in patients with type 2 diabetes
    Wang, Q.
    Zhou, Y.
    Li, L.
    Wang, W.
    Tong, G.
    Shi, B.
    Hu, X.
    Bian, F.
    Li, Q.
    Wang, Y.
    Zhao, N.
    Ma, J.
    Li, Y.
    Zhu, D.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S322 - S323
  • [22] Efficacy and safety of evoglipitin monotherapy in patients with type 2 diabetes
    Kim, D.
    Park, J.
    Park, S.
    Lee, M.
    Yoon, K.
    [J]. DIABETOLOGIA, 2016, 59 : S357 - S358
  • [23] Efficacy and Safety of Supaglutide Monotherapy in Patients with Type 2 Diabetes
    Wang, Qinghua
    Zhou, Yue
    Wang, Weimin
    Tong, Guoyu
    Jia, Weina
    Li, Liang
    Cheng, Zhifeng
    Lu, Yibing
    Shi, Bimin
    Bian, Fang
    Wang, Yihua
    Shi, Xiaoxia
    Li, Qingju
    Su, Xiuhai
    Wang, Kun
    Yuan, Guoyue
    Li, Liping
    Ling, Hongwei
    Hu, Xiaolin
    Wang, Yangang
    Zhao, Naiqing
    Yang, Yehong
    Ma, Jianhua
    Li, Yiming
    Zhu, Dalong
    [J]. DIABETES, 2023, 72
  • [24] A Comparative Study of Safety and Efficacy of Metformin Monotherapy Against Teneligliptin and Metformin in Type 2 Diabetes Mellitus
    Poornima, R.
    Brigida, S.
    Elizabeth, Arul Amutha
    Soujania, G.
    Lella, Tanuja
    [J]. JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 (02) : 7 - 12
  • [25] Efficacy and safety of sitagliptin or rosiglitazone when added to ongoing metformin therapy in patients with Type 2 diabetes
    Scott, Russell
    Loeys, Tom
    Davies, Michael J.
    Engel, Samuel S.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S32 - S32
  • [26] Efficacy and safety of ertugliflozin in patients with type 2 diabetes inadequately controlled with metformin monotherapy: VERTIS MET trial
    Charbonnel, B.
    Pascu, R.
    Frias, J.
    Pall, D.
    Saur, D.
    Darekar, A.
    Huyck, S.
    Shi, H.
    Lauring, B.
    Terra, S.
    Rosenstock, J.
    [J]. DIABETOLOGIA, 2017, 60 : S406 - S407
  • [27] SAFETY AND EFFICACY OF SITAGLIPTIN COMPARED WITH GLIMEPIRIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED WITH METFORMIN MONOTHERAPY
    Abrar, Amjad
    Khan, Shimal
    Rehman, Mehboob Ur
    Jan, Tehmina
    Faisal, Muhammad
    [J]. GOMAL JOURNAL OF MEDICAL SCIENCES, 2013, 11 (01): : 3 - 7
  • [28] The Efficacy and Safety of Imeglimin as Add-On Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
    Fouqueray, Pascale
    Pirags, Valdis
    Inzucchi, Silvio
    Bailey, Clifford J.
    Schernthaner, Guntram
    Diamant, Michaela
    Lebovitz, Harold E.
    [J]. DIABETES, 2012, 61 : A257 - A257
  • [29] The Efficacy and Safety of Imeglimin as Add-on Therapy in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy
    Fouqueray, Pascale
    Pirags, Valdis
    Inzucchi, Silvio E.
    Bailey, Clifford J.
    Schernthaner, Guntram
    Diamant, Michaela
    Lebovitz, Harold E.
    [J]. DIABETES CARE, 2013, 36 (03) : 565 - 568
  • [30] The efficacy and safety of pioglitazone (Actos (TM)) As monotherapy and in combination with glibenclamide or metformin in patients with type 2 diabetes mellitus
    Shestakova, M. V.
    Balabolkin, M. I.
    Antsiferov, M. B.
    Mayorov, A. Y.
    Chugunova, L. A.
    Shamkhalova, M. S.
    Brevnova, N. N.
    Naumenkova, I. V.
    Zaytseva, N. V.
    Tsibina, L. V.
    Dedov, I. I.
    [J]. DIABETES MELLITUS, 2005, 8 (01): : 50 - 57